Eric Lefkofsky is one of the most successful serial entrepreneurs of recent times and is popularly known for his start-up Groupon, which he co-founded. After the success he achieved with Groupon Inc, he went on to found and run many other companies that include Echo Global Logistics, Uptake Technologies, and a few more. Eric Lefkofsky has recently been focusing his attention towards his new health start-up named Tempus, which is a company trying to assemble molecular and clinical data of the cancer patients. Having a digital library of every minute details of treatment and symptoms of cancer patients at one place would help the physicians and oncologists to provide objective and personalized treatment to the patients.
Eric Lefkofsky doesn’t belong to the medical world professionally, but after one of his loved ones suffered from cancer, he got to know about this big loophole when it comes to cancer treatment. He vowed to end the problem and contribute to the cancer treatment progress by the creation of Tempus. In its series E funding recently, Tempus managed to get over $110 million. Eric Lefkofsky believes that the new round of funding would help the company to further its infrastructure development and contribute to its technological interface improvement.
There has been a lot of research on cancer, and by bringing together all the information, it can help doctors take the best decision for their patients. For Eric Lefkofsky, it was never about the profits. He wanted to do something that no one has tried before because of the hard work and dedication it would take. He has been successful in bringing in more hospitals and research institute to share their clinical data that can be included in the program that they are creating for the betterment of the health industry as a whole.